DR Malengreaux SRL
DR Malengreaux reported total assets of €1.07m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Jul 2026).
The score of DR Malengreaux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR Malengreaux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 09 Aug 2023
- Year ended 31 Dec 2021filed on 19 Aug 2022
DR Malengreaux's financial analysis
- Solvency85.9%sector median: 31.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR Malengreaux
DR Malengreaux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0874.672.952
- VAT number
- BE0874672952
- Peppol
- Registered · 0208:0874672952 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Jun 2005
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 21 Jul 2026
- Activity
- Rental and operating of own or leased residential real estate, except social housing (NACE 68201)
DR Malengreaux (SRL) has been based in Waterloo since 2005, active in: rental and operating of own or leased residential real estate, except social housing. For 2025, it reports a net profit of 400,239 € and equity of 919,268 €; its revenue is not published. Its solvency stands at 85.9%, above the median of its sector (31.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR Malengreaux
Companies in the same business, of comparable size and area, outside its group.
- Ryad Immo Rental and operating of own or leased real estate Ixelles · balance sheet €1.07m
- Groenenborg Property Rental and operating of own or leased real estate Antwerp · balance sheet €1.09m
- 3 N Group Rental and operating of own or leased real estate Uccle · balance sheet €1.03m
- Team Invest Belgium Rental and operating of own or leased real estate Ostend · balance sheet €1.07m
- Duquesne-Templeuve Rental and operating of own or leased real estate Tournai · balance sheet €1.07m
- Berry Immo Rental and operating of own or leased real estate Oostrozebeke · balance sheet €1.07m
- Cevamo Rental and operating of own or leased real estate Dendermonde · balance sheet €1.07m
- Belgamer Investments Rental and operating of own or leased real estate Antwerp · balance sheet €1.07m
Frequently asked questions about DR Malengreaux
What is the revenue of DR Malengreaux?
DR Malengreaux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR Malengreaux?
In Belgium, the VAT number is the company number prefixed with BE: BE0874672952 for DR Malengreaux, if the company is VAT-registered. Its company number (CBE) is 0874.672.952.
Where is the registered office of DR Malengreaux?
According to the CBE register, the registered office of DR Malengreaux is in 1410 Waterloo.
What is the equity of DR Malengreaux?
At the close of the 2025 financial year, the equity of DR Malengreaux amounts to 919,268 €, a solvency of 85.9% of total assets.
Who manages DR Malengreaux?
The register lists 3 active mandates at DR Malengreaux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR Malengreaux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →